UK Markets open in 1 hr 33 mins

Sesen Bio, Inc. (SESN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.5419+0.0067 (+1.25%)
At close: 01:00PM EST
0.5300 -0.01 (-2.20%)
After hours: 03:59PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.86
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 31.1300
52-week low 30.3650
50-day moving average 30.5148
200-day moving average 30.6121

Share statistics

Avg vol (3-month) 31.05M
Avg vol (10-day) 3710.4k
Shares outstanding 5199.46M
Implied shares outstanding 6N/A
Float 8199.45M
% held by insiders 10.28%
% held by institutions 114.46%
Shares short (13 Oct 2022) 43.23M
Short ratio (13 Oct 2022) 42.28
Short % of float (13 Oct 2022) 41.60%
Short % of shares outstanding (13 Oct 2022) 41.60%
Shares short (prior month 14 Sept 2022) 43.81M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 239.25%
Operating margin (ttm)-342.85%

Management effectiveness

Return on assets (ttm)-20.54%
Return on equity (ttm)49.92%

Income statement

Revenue (ttm)20M
Revenue per share (ttm)0.10
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)1.23M
EBITDA -68.54M
Net income avi to common (ttm)47.85M
Diluted EPS (ttm)-0.1910
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)141.54M
Total cash per share (mrq)0.71
Total debt (mrq)41.7k
Total debt/equity (mrq)0.03
Current ratio (mrq)4.89
Book value per share (mrq)-0.07

Cash flow statement

Operating cash flow (ttm)-28.7M
Levered free cash flow (ttm)-13.83M